What can the practitioner expect from and contribute to drug surveillance
Simon, P.
La Revue du Praticien 26(5): 283-4 7-9
1976
ISSN/ISBN: 0035-2640 PMID: 1273470 Document Number: 108772
Document emailed within 1 workday
Related Documents
Rioufol, C.; Vial, T.; Pulce, C.; Descotes, J. 2002: Correspondents in post- marketing surveillance, drug dependence surveillance, and toxicovigilance: definition and roles Therapie 57(2): 201-204Strandberg, K. 2006: Sweden can contribute to safer drug assessment Lakartidningen 103(23): 1853-1855
Joel, S.; Maxwell, J.A.; Khera, D.; Peetz, J.; Baucom, B.R.W.; MacDonald, G. 2023: Expect and you shall perceive: people who expect better in turn perceive better behaviors from their romantic partners Journal of Personality and Social Psychology 124(6): 1230-1255
Miller, R.R. 1974: Drug surveillance and drug usage studies: what are they and how do they differ? American Journal of Hospital Pharmacy 31(5): 492-493
Paul, A.H. 1972: The general practitioner and drug dependence New Zealand Medical Journal 76(485): 278-279
Nemitz, I. 1986: The general practitioner, his patients and drug compliance Therapeutische Umschau. Revue Therapeutique 43(8): 650-653
Beling, M. 1980: The general practitioner confronted with the drug demanding patient Lakartidningen 77(6): 426-427
Băicuş, C.; Chivu, R. 2004: Drug politics--economic view-point of a practitioner Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 108(3): 674-678
Wunder, S.; Brune, K. 2004: Drug prescribing in practitioner networks--improved treatment at no extra cost? MMW Fortschritte der Medizin 146(51-52): 43-44
Fleury, L.; Cornet, M. 2000: Surveillance épidémiologique de l'aspergillose invasive : dans quels services, quels dénominateurs, place de la surveillance multicentrique - Epidemiological surveillance of invasive aspergillosis (IA) : which wards, which denominators, relevance of multicentric surveillance Prevention du Risque Aspergillaire chez les Patients Immunodeprimes 8(6): 418-425
Binder, P. 1994: Can the general practitioner care for outpatient drug addicts without substitution treatments? what products can he use? Annales de Medecine Interne 145(Suppl 3): 62-64
Shah, Z.; Ali, M.; Hussain, I.; Farooqui, S.Z.; Ali, A.N.A.; Ali, A.W.; Arain, F.M.; Allana, S.S.; Aarabi, S.R.; Khan, S.F.; Arif, M.; Siddique, S.; Shafiq, M.; Lakhani, A.B. 2009: General practitioner's knowledge regarding the diagnosis and drug therapy for acute myocardial infarction JPMA. Journal of the Pakistan Medical Association 59(2): 118-122
Tanmoy, A.M.; Ahmed, A.N.U.; Arumugam, R.; Hossain, B.; Marzan, M.; Saha, S.; Arifeen, S.E.; Baqui, A.H.; Black, R.E.; Kang, G.; Saha, S.K. 2016: Rotavirus Surveillance at a WHO-Coordinated Invasive Bacterial Disease Surveillance Site in Bangladesh: a Feasibility Study to Integrate two Surveillance Systems Plos one 11(4): E0153582
Macrì, A.; Marabelli, R. 1992: Veterinary drug surveillance Annali Dell'istituto Superiore di Sanita 28(4): 421-424
Busto, U.; Ruiz, I.; Naranjo, C.A.; González, G.; Domecq, C.; Castillo, M. 1978: Drug surveillance using trained pharmacists Revista Medica de Chile 106(3): 188-191
Zink, C.D. 1979: Depression from the viewpoint of the general practitioner. A report of experiences from a practitioner to practitioners Die Medizinische Welt 30(40): 1468-1471
Gc, G.; Rijal, B.; Sharma, A P. 2003: Surveillance of Anti-Tubercular Drug Resistance Journal of Nepal Medical Association 41(142): 311-313
Saxena, S.N.; Kumari, N.; Saini, S.S.; Soni, D.V.; Pahwa, R.K.; Jayasheela, M. 1989: Surveillance of salmonellae in India for drug resistance Indian Journal of Medical Sciences 43(6): 145-150
Gc, G.; Rijal, B.; Sharma, A P. 2003: Surveillance of Anti-Tubercular Drug Resistance Journal of Nepal Medical Association 41(142): 311-313
Vinti, H.; Taillan, B.; Chichmanian, R.M.; Fuzibet, J.G.; Pesce, A.; Cassuto, J.P.; Dujardin, P. 1989: Drug surveillance of beta-blockers in eyedrops Presse Medicale 18(5): 231